Thompson Rahsaan 4
4 · Lyell Immunopharma, Inc. · Filed Oct 12, 2022
Insider Transaction Report
Form 4
Thompson Rahsaan
Chief Legal Officer
Transactions
- Award
Option (right to buy)
2022-10-10+715,000→ 715,000 totalExercise: $6.91Exp: 2032-10-09→ Common Stock (715,000 underlying)
Footnotes (1)
- [F1]1/4 of the option shares shall vest on September 28, 2023, with the remaining option shares to vest in equal monthly installments over the following thirty-six months.